1. Home
  2. PZG vs BSEM Comparison

PZG vs BSEM Comparison

Compare PZG & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paramount Gold Nevada Corp.

PZG

Paramount Gold Nevada Corp.

SELL

Current Price

$0.94

Market Cap

84.0M

ML Signal

SELL

Logo BioStem Technologies Inc. Common Stock

BSEM

BioStem Technologies Inc. Common Stock

HOLD

Current Price

$0.96

Market Cap

76.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZG
BSEM
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.0M
76.9M
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
PZG
BSEM
Price
$0.94
$0.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 265.9K
263.2K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $330,259.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$87.68
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.88
$0.90
52 Week High
$2.70
$5.44

Technical Indicators

Market Signals
Indicator
PZG
BSEM
Relative Strength Index (RSI) 41.67 31.84
Support Level $0.88 N/A
Resistance Level $1.06 $4.65
Average True Range (ATR) 0.07 0.25
MACD 0.01 0.06
Stochastic Oscillator 37.86 8.33

Price Performance

Historical Comparison
PZG
BSEM

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold and Bald Peak Project.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: